Home › Compare › SHKBF vs ABBV
SHKBF yields 4.57% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, SHKBF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHKBF + ABBV for your $10,000?
Shibuya Corporation manufactures and sells packaging and mechatronics systems in Japan and internationally. The company offers bottling systems for SAKE and distilled spirit bottling system, liquor bottling system, beer bottling system, dairy product bottling system, seasoning bottling system, cooking oil bottling system, cosmetics bottling system, personal care products bottling system, chemical product bottling system, health and nutritional drink bottling system, and mineral water bottling system; and packaging systems, such as caser/uncaser, wrap-around caser, cartoning, case former, case sealing, multi packer, cup filling/sealing, cup and tray sealing, pouch filling and sealing, gusset packaging, corrugate sheet providing, container folding assembly, polyethylene film applicator, poly bag sealing, and packaging system machines. It also provides pharmaceutical manufacturing systems, including isolator systems, sterilization/decontamination systems, filling systems, validation, preparation facilities, and various pharmaceutical manufacturing systems; regenerative medicine manufacturing systems; super heated steam cooking system and ultra-high pressure processing system; and production management systems. In addition, the company provides fiber laser cutting machines; CO2 laser cutting machines; YAG laser welding machines, laser ablation machines, laser/water cutting machines, water jet cutting machines, other cutting machines, and hydraulic presses; solder ball mounter, bonders for optical communication and optical devices, flip chip bonders/high-accuracy die bonders, high-accuracy bonders for image sensors, wire bonder, LED inspection/sorting/taping machines, 3D vision inspection systems, and battery manufacturing systems; medical equipment systems; cleaning / environmental equipment systems; and agricultural equipment systems. Shibuya Corporation was founded in 1931 and is headquartered in Kanazawa, Japan.
Full SHKBF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.